跳至主要内容
临床试验/NCT06628167
NCT06628167
已完成
不适用

Community Support Program for Lung Cancer Screening Volume II

Abramson Cancer Center at Penn Medicine2 个研究点 分布在 1 个国家目标入组 252 人2024年10月1日
适应症Lung Cancer

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Lung Cancer
发起方
Abramson Cancer Center at Penn Medicine
入组人数
252
试验地点
2
主要终点
Scheduled Lung Cancer Screening Appointments Attended by Participants
状态
已完成
最后更新
上个月

概览

简要总结

This is a West Philadelphia based community project to improve adherence to lung cancer screening. The overall objective of this project is to demonstrate the impact of a community support program (CSP) on improve adherence to LCS follow-up guidelines in an urban environment. The study will target individuals in the Penn Medicine healthcare system residing in Philadelphia with an upcoming or missed follow-up screening or orders placed but who have not yet scheduled their screenings by offering free transportation coordination to and from the appointment. The study team will also offer to connect those with placed but unscheduled low dose CT orders to connect with Penn Medicine's scheduling staff.

注册库
clinicaltrials.gov
开始日期
2024年10月1日
结束日期
2026年2月1日
最后更新
上个月
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

入排标准

入选标准

  • Upcoming or missed low dose CT for lung cancer screening
  • Philadelphia resident

排除标准

  • Lives outside Philadelphia city limits

结局指标

主要结局

Scheduled Lung Cancer Screening Appointments Attended by Participants

时间窗: 12 months

The Primary Outcome measures appointment attendance across three groups: West Philadelphia CSP Participants (eligible West Philadelphia residents who opted into the CSP), West Philadelphia Non CSP Participants (eligible West Philadelphia residents who did not opt into the CSP), and Southwest Philadelphia Residents (patients who did not receive an option to participate in the CSP).

次要结局

  • CSP Enrollment(12 months)

研究点 (2)

Loading locations...

相似试验